2020 Beyond BioMed Accelerator is held by AstraZeneca in collaboration with BioHub [email protected], Amazon Web Services (AWS). The program will promote the acceleration of the biomedical industry, innovation in medical technology and services.

Startup teams participating in the program would have the privilege to receive mentoring and support from internationally renowned institutions in the biomedical industry. Winner teams would be eligible for three months of intensive acceleration program, one-on-one academic and commercial mentoring. Throughout the program, the teams would be able to connect with prominent scientists and entrepreneurs and become part of a global network. We are looking for startups in the two major professional fields as follows: Digital Health and BioMedicine.
In contrast to traditional science parks that focus on manufacturing and production, the National Biotechnology Research Park facilitates innovative research by closely integrating key institutions to create an efficient cluster effect. These institutions include the Food and Drug Administration of the Ministry of Health and Welfare, the National Laboratory Animal Center of the Ministry of Science and Technology, the Biotechnology Development Center of the Ministry of Economic Affairs, and the Biomedical Translation Research Center of Academia Sinica.
Read more
AstraZeneca (LSE/STO/NYSE: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Read more
In 2006, Amazon Web Services (AWS) began offering IT infrastructure services to businesses in the form of web services -- now commonly known as cloud computing. One of the key benefits of cloud computing is the opportunity to replace up-front capital infrastructure expenses with low variable costs that scale with your business. With the Cloud, businesses no longer need to plan for and procure servers and other IT infrastructure weeks or months in advance. Instead, they can instantly spin up hundreds or thousands of servers in minutes and deliver results faster.
Read more
Application criteria & selection
  • Team eligibility:
    • The application is open to all companies and teams, in any nationalities or ages
    • The team must be able to attend mentoring and courses in English
  • Professional fields:
    1. Category A: Digital Health
      Digital Health innovative projects, solutions or compounds that providing solutions to current unmet patients’ needs such as:
      • Awareness
      • Early detection and Diagnosis
      • Treatment
      • Post-treatment wellness
    2. Category B: BioMedicine
      Biomedical Innovative projects, solutions or compounds for patients that targeting the following 3 disease areas:
      • Oncology
      • Respiratory and Immunology
      • Cardiovascular, Renal and Metabolism
  • Judging criteria
    1. Overall planning: understanding of the problem, novelty, and feasibility of the solution. The score would include current validation (operational) results, market development plan, product development plan, and fundraising plan.
    2. Market potential: understanding of the market growth, competitor analysis, and the team’s competitive edge
    3. Execution: the team’s background, past achievements and results, teamwork and ability to carry out its plans
    4. Collaboration potential: the team’s potential in collaborating with the accelerators’ enterprise partner(s) from technology, service, or market aspects. Preferences would be given to teams have sufficient condition to collaborate with the enterprise partners.
Important dates
Phase 1: application and selection
Phase 2: acceleration
*When the event cannot be carried out smoothly for any reason, the organizer reserves the right to modify, postpone, suspend or terminate the course at any time.
Online briefing Video
Content
a. About「 2020 Beyond BioMed Accelerator 」
b. Our Purpose
c. Academia Sinica Resources
d. About 「iDREAM」Project - Astrazeneca
e. About 「2019 Winner Team」
f. Application Criteria & Selection-BioMed
g. AZ Resources
h. Startup Experience Sharing - AWS
i. AWS Resources
j. Application Criteria & Selection-Digital Health
If you have any question, please feel free to ocntact us:
[email protected]
2019 Recap
ATP BioPharm
這次很榮幸入選參加生醫加速器活動,主辦單位針對各種主題,如:生醫產業分析、投資人觀點、Pitch訓練等等,透過系列演講及互動,提供新創團隊與各領域人士接觸和建議。期間主辦方特別聘請專業講師,透過一對一的方式,給予團隊行銷內容上的建議及提升流暢度,對新創團隊而言,如何使用淺顯易懂的方式行銷自己給大眾,並深入淺出地闡述自己的獨特性,這對後續獲得投資的重要性不言而喻。最後團隊更有機會能直接面對國際大藥廠AstraZeneca商業發展部門人員,提供團隊合適的產業連結和各領域指導,提供團隊後續發展重大的幫助。
賽昂生醫 CYTOARM TMU KHC Team
感謝NBRP和AstraZeneca提供難得的機會,讓我們學習創業、募資、資金結構和公司營運,整個課程相當全面,資深的專業講師也能由淺入深地分享經驗和教授課程內容,其中印象最深刻的是Presentality公司的講師一對一指導每位成員簡報的語言表達和肢體動作,過程相當細心。也感謝遠在AZ英國的BD專家Laura為我們尋求AZ資深研究團隊的建議。在經由數月的課程和修改Pitch簡報後,我們於Demo Day展現本次培訓的進步成果,有幸獲得AZ國際專家的寶貴意見和正面讚賞,讓我們更有信心踏入創業路,於2020年初正式成立賽昂生醫,期許能成功推動次世代的T細胞療法技術,造福更多的癌症病患。
酷氏基因生物科技股份有限公司 Guzip
謝謝NBRP BIOMED STARTUP國際生醫加速器的育成輔導及資源引進,加速器培訓計畫過程中曾安排多次與臺灣及國際業師的一對一專屬輔導,受益良多,對於新產品國際佈局及醫療市場定位有更深入的理解及掌握。
具體收穫包括:
1. 媒體曝光
2. 提供多場法律、專利和財務等相關知識課程供團隊自由參加
3. 臺灣AstraZeneca 及英國AstraZeneca的輔導諮詢
4. 國際臨床合作夥伴的引薦及媒合
精拓生技股份有限公司 Cancerfree biotech
精拓生技的核心技術專注於循環腫瘤細胞的體外培養,對於癌症精準醫療市場是相當新穎的概念。因此很榮幸可以獲選參與國家生技園區、阿斯特捷利康藥廠以及台北醫學大學所共同舉辦的iDream 計畫。在計畫過程除了可以跟其他高技術含量的優秀團隊交流,也可以獲得國內外一流業師的輔導,尤其能與阿斯特捷利康團隊直接對談,讓我們更為了解國際藥廠思維以及可能的合作模式。此外,生醫產品的驗證需要透過嚴謹的臨床驗證,我們也透過課程跟台北醫學大學的輔導,與CRO公司正在洽談進一步的臨床驗證規劃。
生德奈生物科技股份有限公司 Cytena biosciences
非常感謝AstraZeneca協助生德奈鏈結國際市場以及無私引薦其他國際藥廠的機會,讓生德奈在計劃過程中學習到更多實際藥廠製造流程並累積更多人脈,目前順利地將第一代c.bird產品推廣至美國AstraZeneca,是一個重要的里程碑,感謝AstraZeneca發起這個對它們國際藥廠而言是nonprofit的計畫,但是可以真的提供新創公司寶貴的顧問與資源,帶動台灣生醫發展建立起新創生醫生態圈,邁向國際舞台。
Anbogen Therapeutics, Inc. (ABT)
The program has been instrumental in helping the startup companies to launch and to be connected with investors and plenty of business opportunities. Many lecturers are enthusiastic in sharing their biotech startup experiences. Through the program, I’ve gained a clear whole picture what it takes to bring scientific discovery into commercialization.
醫守科技股份有限公司 AESOP
這次的國際生醫加速器計畫,和以往參加過的加速器非常不同,中研院、AstraZeneca及北醫在生醫及醫療領域深耕許久,因此能夠真正了解團隊的語言、進行有效溝通,並且照顧各個團隊的需求。
在3個月培訓課程中,所接觸到的專業性領域及建議,也都是以往不曾有過、有別於以往的學習資源。也因為參與此次AstraZeneca的加速器計劃,我們在發展的過程中擁有更多被國際舞台看見的機會,甚至很榮幸的被美國矽谷團隊選為合作夥伴,順利與國際接軌鏈結。
中央研究院 生物醫學科學研究所 Academia Sinica - Amnion Biosciences
非常感謝主辦單位能夠舉辦這樣的加速器計劃,對於學術界來說,不再只是閉門研究,透過加速器是能用完全不同視野來看生技發展、並幫助與產業鏈接軌。在加速器計劃中和AstraZeneca許多跨國團隊交流,在學術研究上&如何有效推廣得到了非常大的幫助,學術研究人員可以在研究過程中隨時做調整、並實際了解臨床上的需求去做改進。也希望未來這樣子的研究技術轉譯,能更有效推廣學術界以上,包括:學校老師、教授及中研院研究員…等,相信對台灣生技發展也會有非常大的幫助。
News
Latest News